ArticleMedical oncology (Northwood, London, England)2025
NFATC3 enhances osteosarcoma progression by increasing PD-L1 and CXCL2 levels.
Feiyuan Liang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleMedical oncology (Northwood, London, England)2025
Feiyuan Liang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.